DPP-4-IN-16 (Compound 92) is a potent inhibitor of dipeptidyl peptidase-4 (DPP-4) with an IC50 of 0.8 nM. It effectively inhibits the degradation of incretins such as GLP-1 and GIP by DPP-4, thereby enhancing insulin secretion and lowering blood glucose levels. DPP-4-IN-16 holds potential for research into type 2 diabetes.
Target:
Proteasome
* VAT and and shipping costs not included. Errors and price changes excepted
